SCHEMBL24378511

SCHEMBL24378511

CC1O[C@H](COC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.54
POLB P06746 2/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
PTPN1 P18031 4/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 1/20 0.48
F11 P03951 2/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 1/20 0.46
GAPDH P04406 2/20 0.46
ELANE P08246 1/20 0.46
MAPK1 P28482 2/20 0.45
TMPRSS2 O15393 1/20 0.45
PDE5A O76074 1/20 0.45
HMGCR P04035 1/20 0.45
CYP1A2 P05177 1/20 0.45
LCK P06239 1/20 0.45
FYN P06241 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14005673 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL20739194 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL23895306 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL12300564 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL21754836 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL12222446 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL21754881 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL15759263 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL18871302 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL25506254 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF SICHUAN UNIVERSITY (CN) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF UGGT1, ALG8, FUT6 USP2 3876/4885POLB 2983/4885MEN1 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.